Publications Office of the EU
Poland-Dębno: Pharmaceutical products - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Poland-Dębno: Pharmaceutical products

  • Published
    14/11/2023
  • Deadline
    14/12/2023
  • Opening of tenders
    14/12/2023
  • Awarded
    03/01/2024
  • Today
    27/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Szpital w Dębnie im. Św. Matki Teresy z Kalkuty
Place of performance
NUTS code: PL428 Szczeciński
Location of buyer
NUTS code: PL42 Zachodniopomorskie
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
1,064,923.75 EUR
Please consult each lot for details
Number of lots
21
Tender reference number
Not available
Description

Zamówienie obejmuje sukcesywną dostawę leków dla Szpitala w Dębnie w 2024r.

Submission Method
Tenders or requests to participate must be submitted to:
Official name: Szpital w Dębnie im. Św. Matki Teresy z Kalkuty
National registration number: 5971730353
Postal address: Kościuszki 58
Town: Dębno
NUTS code: PL42
Postal code: 74-400
Country: POL
Main address: www.bip.szpital.debno.com.pl
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
14/12/2023 10:30
Place of performance
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.